The Pathology of Gastric and Duodenal Polyps

Introduction to Gastric and Duodenal Polyps

  • Liberal use of upper endoscopy allows for increased detection of gastric and duodenal polyps, found in approximately 6% and 4.6% of examinations, respectively.

  • Polyps can be neoplastic (potentially malignant) or non-neoplastic (e.g., hyperplastic).

  • Characteristic topographical features, endoscopic appearance, and associated mucosal pathologies (e.g., Helicobacter pylori, autoimmune gastritis) guide the evaluation of polyps.

  • Classifications:

    • Polyps arise from

      • Surface epithelium (foveolar/intestine type)

      • Deeper glandular components (e.g., pyloric/oxyntic gland derived).

Classification of Polyps

  • Surface Epithelium-Derived Polyps

    • Hyperplastic Polyps:

      • Most common gastric polyps, particularly in those aged 60-80.

      • Associated with gastritis:

        • Intestinal metaplasia (37%)

        • H. pylori infection (25%)

        • Chemical/Reactive gastropathy (21%).

    • Gastric Fundic Gland Polyps (FGPs):

      • Increased incidence related to proton pump inhibitors (PPIs); their incidence went from 8.8% to 66% in one study.

    • Adenomas:

      • Comprise only 1-10% of gastric polyps, with intestinal-type adenomas being the most common.

Specific Types of Gastric Polyps

Hyperplastic Polyps
  • Typically solitary, predominantly found in the antrum (60%).

  • May be broad-based, smooth, and lobulated, with sizes generally under 20 mm but capable of growing larger.

  • Risk of neoplastic transformation increases with size (>25 mm).

  • Histological Characteristics:

    • Irregular, elongated, tortuous pits with cystic dilations.

    • Foveolar epithelium with an apical neutral mucin cap seen under microscopic examination with specific staining protocols (e.g., Alcian blue staining).

    • May exhibit mucosal prolapse phenomenon in certain cases, especially in the antropyloric area.

Gastric Fundic Gland Polyps (FGPs)
  • Small, round, smooth-surfaced polyps found in oxyntic mucosa, often with a background of normal mucosa or minimal inflammation.

  • Diagnostic implications vary based on their association with syndromes (e.g., FAP, GAPPS).

Adenomas
  • Two histological types: Intestinal-type (56%) and Foveolar-type (41%).

  • Pathological features of intestinal adenomas resemble those of colonic adenomas and typically arise from regions with chronic changes (gastritis).

  • Endoscopic and histological management considerations advised based on size and dysplasia.

Diagnosis and Management Strategies

  • Assess surrounding mucosa: Essential for accurate diagnosis as polyps are frequently associated with adjacent pathologies, including chronic gastritis and H. pylori infection.

  • Management strategies vary:

    • Endoscopic resection recommended for polyps >10 mm or those with dysplastic changes; smaller lesions may be monitored.

    • Regular follow-ups after resection to monitor for recurring lesions or malignant transformations.

Duodenal Polyps

  • Located mainly within the ampullary region with a significant association with FAP and MAP syndromes.

  • Most duodenal polyps identified are adenomatous, and pathological characteristics similar to colonic adenomas are common.

  • Duodenal Gastric Heterotopia and Brunner Gland Hyperplasia:

    • Distinct from adenomatous lesions and non-neoplastic hyperplastic nodules; maintenance of lobular architecture can aid diagnosis.

Syndromes Associated with Polyps

  • Various genetic syndromes lead to the development of gastric and duodenal polyps:

    1. Familial Adenomatous Polyposis (FAP): Associated with FGPs and duodenal adenomas, presenting significant cancer risk in aged populations.

    2. Peutz-Jeghers Syndrome: Presents hamartomatous polyps with gastrointestinal and extra-intestinal manifestations.

    3. Cowden Syndrome: Related to multiple hamartomatous polyps, requiring careful management.

Summary

  • Emerging management guidelines highlight the importance of early detection and classification of gastric and duodenal polyps for preventive healthcare.

  • Continuous research and surveillance are critical for understanding inheritance patterns, managing risks, and improving patient outcomes regarding polyp-associated malignancies.